Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard
Author:
Affiliation:
1. Department of Neurology; University of Maryland; Baltimore Maryland U.S.A
2. Food and Drug Administration; White Oak Maryland U.S.A
3. Department of Pharmaceutical Sciences; University of Maryland; Baltimore Maryland U.S.A
Funder
FDA
University of Maryland Clinical Translational Science Institute
University of Maryland General Clinical Research Center
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/epi.13095/fullpdf
Reference44 articles.
1. Understanding the scientific issues embedded in the generic drug approval process;Welage;J Am Pharm Assoc,2001
2. IMS Institute for Healthcare Informatics Medicine Use and Shifting Costs of Healthcare: A Review of the Use of Medicines in the United States in 2013 http://www.imshealth.com/cds/imshealth/Global/Content/Corporate/IMS%20Health%20Institute/Reports/Secure/IIHI_US_Use_of_Meds_for_2013.pdf
3. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy;Liow;Neurology,2007
4. American Epilepsy Society Position Statement on the Substitution of Different Formulations of Antiepileptic Drugs for the Treatment of Epilepsy https://www.aesnet.org/sites/default/files/file_attach/AboutAES/PositionStatements/position%20statement%20on%20substitution%20of%20generic%20formulations.pdf
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Correlation between prescription volumes of generic antiepileptic drugs and the number of clinical epileptologists acccross prefectural regions in Japan: a descriptive study using a national claims database.;Clinical Neurology and Neurosurgery;2024-09
2. Lamotrigine add-on therapy for drug-resistant focal epilepsy;Cochrane Database of Systematic Reviews;2023-12-11
3. Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region;Neurology and Therapy;2023-05-24
4. Dissolution-Hollow Fiber Membrane (D-HFM) System to Anticipate Biopharmaceutics Risk of Tablets and Capsules;Journal of Pharmaceutical Sciences;2023-03
5. Generic lamotrigine extended‐release tablets are bioequivalent to innovator drug in fully replicated crossover bioequivalence study;Epilepsia;2022-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3